First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors
Graphical abstract
Section snippets
Acknowledgements
Research reported in this publication was supported by the National Institute of Allergy and Infectious Disease of the National Institutes of Health under award number 1R01AI136795 (A.S.D. and H.I.Z), by a Project Development Team within the Indiana CTSI NIH/NCRR Grant Number UL1TR001108 (S.M.S), and by the Chemical Genomics Core facility in the Indiana CTSI. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes
References (22)
- et al.
The global need for effective antibiotics: challenges and recent advances
Trends Pharmacol Sci
(2010) - et al.
Involvement of the Cpx signal transduction pathway of E. coli in biofilm formation
FEMS Microbiol Lett
(1999) - et al.
Genome-wide profiling of promoter recognition by the two-component response regulator CpxR-P in Escherichia coli
J Biol Chem
(2002) - et al.
Two-component signal transduction as potential drug targets in pathogenic bacteria
Curr Opin Microbiol
(2010) - et al.
Protein kinases as antibacterial targets
Curr Opin Cell Biol
(2009) - et al.
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America
Clin Infect Dis
(2009) - et al.
Novel approaches to developing new antibiotics for bacterial infections
Br J Pharmacol
(2007) - et al.
Novel classes of antibiotics or more of the same?
Br J Pharmacol
(2011) - et al.
Trends in antimicrobial drug development: implications for the future
Clin Infect Dis
(2004) - et al.
Anti-virulence strategies to combat bacteria-mediated disease
Nat Rev Drug Discov
(2010)
Two-component signal transduction
Annu Rev Biochem
Cited by (12)
Bacterial envelope stress responses: Essential adaptors and attractive targets
2023, Biochimica et Biophysica Acta - Molecular Cell ResearchCitation Excerpt :Broad-spectrum antimicrobials may increase selection pressure for the development of resistance, and inhibition or deletion of ESRs has proven to have specific but nonetheless detrimental effects on pathogen growth in vivo (see previously in this review). A series of recent studies have investigated CpxA phosphatase inhibitors as novel anti-virulence drugs [327–329]. Following on studies showing that aberrant Cpx activation attenuates virulence in Salmonella sp. and H. ducreyi, van Rensburg and colleagues conducted a screen for compounds activating a Cpx-regulated lacZ reporter [327].
Novel medicinal and synthetic chemistry strategies against antimicrobial resistance
2022, Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial ResistanceGuiding the Way: Traditional Medicinal Chemistry Inspiration for Rational Gram-Negative Drug Design
2024, Journal of Medicinal ChemistryStructure-Uptake Relationship Studies of Oxazolidinones in Gram-Negative ESKAPE Pathogens
2022, Journal of Medicinal Chemistry
- 1
Authors contributed equally.